JEOL Ltd
TSE:6951

Watchlist Manager
JEOL Ltd Logo
JEOL Ltd
TSE:6951
Watchlist
Price: 4 930 JPY 0.26% Market Closed
Market Cap: 254B JPY

Profitability Summary

JEOL Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
JEOL Ltd

Revenue
200.5B JPY
Cost of Revenue
-106.8B JPY
Gross Profit
93.6B JPY
Operating Expenses
-56.4B JPY
Operating Income
37.2B JPY
Other Expenses
-17.8B JPY
Net Income
19.5B JPY

Margins Comparison
JEOL Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
JEOL Ltd
TSE:6951
252.2B JPY
47%
19%
10%
US
Abbott Laboratories
NYSE:ABT
215.9B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
193.8B USD
66%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
135.8B USD
69%
19%
14%
US
Stryker Corp
NYSE:SYK
135.2B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
127.3B USD
66%
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
49.2B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
56.7B USD
46%
16%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.1B USD
62%
31%
25%
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
78%
28%
23%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.2B USD
41%
14%
11%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
JEOL Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
JEOL Ltd
TSE:6951
252.2B JPY
15%
9%
25%
16%
US
Abbott Laboratories
NYSE:ABT
215.9B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
193.8B USD
17%
15%
17%
22%
US
Boston Scientific Corp
NYSE:BSX
135.8B USD
13%
7%
11%
9%
US
Stryker Corp
NYSE:SYK
135.2B USD
14%
6%
14%
12%
IE
Medtronic PLC
NYSE:MDT
127.3B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
49.2B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
56.7B USD
7%
3%
7%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.1B USD
65%
31%
58%
35%
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
14%
10%
14%
16%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.2B USD
24%
6%
11%
8%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less